Nautilus Biotechnology is trading 5.12% up now at $2.26 amid a stronger biotech backdrop. - The XBI is reported up 2.01%, with sentiment lifted by Moderna’s earnings and outlook; broader U.S. indexes are also positive. - No company-specific announcement was found on November 6. - Its latest listed company release was its October 27 third-quarter results.